Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Identification of Critical Phosporylation Sites within NPM-ALK That Regulate JUNB mRNA Translation.

Claudia Fuchs, Paul Vesely, Ms, Isabella Bambach, Silvia Schauer, Werner Linkesch, MD, David W. Sternberg, MD, PhD, Gerald Hoefler, MD, Philipp B. Staber, MD

Blood (2007) 110 (11): 3571.

https://doi.org/10.1182/blood.V110.11.3571.3571

Published: 2007

Journal Articles

NPM-ALK Fusion Tyrosine Kinase of Anaplastic Large Cell Lymphoma Exerts Its Transforming Potential by Increasing Translation of JUNB through mTOR and S6K1.

Philipp B. Staber, MD, Paul Vesely, MS, Rene Ott, PhD, Naznin Haq, Werner Linkesch, MD, Silvia Schauer, Andelko Hrzenjak, PhD, Lukas Kenner, MD, Wilhelm Dirks, PhD, Marshall E. Kadin, MD, David W. Sternberg, MD PhD, Gerald Hoefler, MD

Blood (2006) 108 (11): 1428.

https://doi.org/10.1182/blood.V108.11.1428.1428

Published: 2006

Journal Articles

NPM-ALK Converts JUNB from a Tumor Suppressor to an Oncogene.

Paul Vesely, MS, Philipp B. Staber, MD, Rene Ott, PhD, Montserrat Pinent, PhD, Werner Linkesch, MD, Silvia Schauer, Andelko Hrzenjak, PhD, Marshall E. Kadin, MD, David W. Sternberg, MD PhD, Gerald Hoefler, MD

Blood (2006) 108 (11): 1448.

https://doi.org/10.1182/blood.V108.11.1448.1448

Published: 2006

Journal Articles

Genes Regulated by NPM-ALK Fusion Kinase Play a Key Role in the Activation of AP-1 Transcription Factors.

Philipp B. Staber, MD, Werner Linkesch, MD, Silvia Schauer, Gerit Moser, Marshall E. Kadin, MD, Willi Dirks, PhD, Gerald Hoefler, MD

Blood (2004) 104 (11): 245.

https://doi.org/10.1182/blood.V104.11.245.245

Published: 2004

Journal Articles

Two Novel Activating Germline Mutations of the C-RAF Proto-Oncogene Predisposing to Solid Tumors and Therapy-Related Acute Myeloid Leukemia.

Armin Zebisch, MD, Philipp B. Staber, MD, Katja Fischereder, Claudia Bodner, Karin Hiden, Werner Linkesch, MD, Holger W. Auner, MD, Werner Emberger, MD, Christian Windpassinger, PhD, Michael G. Schimek, PhD, Gerald Hoefler, MD, Jakob Troppmair, PhD, Heinz Sill, MD

Blood (2004) 104 (11): 3370.

https://doi.org/10.1182/blood.V104.11.3370.3370

Published: 2004

NARROW

Identification of Critical Phosporylation Sites within NPM-ALK That Regulate JUNB mRNA Translation.

NPM-ALK Fusion Tyrosine Kinase of Anaplastic Large Cell Lymphoma Exerts Its Transforming Potential by Increasing Translation of JUNB through mTOR and S6K1.

NPM-ALK Converts JUNB from a Tumor Suppressor to an Oncogene.

Genes Regulated by NPM-ALK Fusion Kinase Play a Key Role in the Activation of AP-1 Transcription Factors.

Two Novel Activating Germline Mutations of the C-RAF Proto-Oncogene Predisposing to Solid Tumors and Therapy-Related Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Identification of Critical Phosporylation Sites within NPM-ALK That Regulate JUNB mRNA Translation.

NPM-ALK Fusion Tyrosine Kinase of Anaplastic Large Cell Lymphoma Exerts Its Transforming Potential by Increasing Translation of JUNB through mTOR and S6K1.

NPM-ALK Converts JUNB from a Tumor Suppressor to an Oncogene.

Genes Regulated by NPM-ALK Fusion Kinase Play a Key Role in the Activation of AP-1 Transcription Factors.

Two Novel Activating Germline Mutations of the C-RAF Proto-Oncogene Predisposing to Solid Tumors and Therapy-Related Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only